Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lipocine Inc (NASDAQ:LPCN)

12.36
Delayed Data
As of 3:59pm ET
 +0.17 / +1.39%
Today’s Change
3.70
Today|||52-Week Range
14.48
+134.98%
Year-to-Date
No recent news for Lipocine Inc.

Today’s Trading

Previous close12.19
Today’s open11.84
Day’s range11.76 - 12.47
Volume139,062
Average volume (3 months)249,531
Market cap$221.9M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-11.11%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.92

Competitors

 Today’s
change
Today’s
% change
MRNSMarinus Pharmaceutic...+0.89+5.71%
HSKAHeska Corp-0.65-1.89%
VTAEVitae Pharmaceutical...+0.09+0.88%
ITEKInotek Pharmaceutica...-0.45-3.36%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$20.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Mahesh V. Patel
Chief Financial Officer, Secretary, CAO &
EVP
Morgan R. Brown
Corporate headquarters
Salt Lake City, Utah

Forecasts